Clinical Trial Update: Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating the combination of efaproxiral and carmustine for progressive or recurrent malignant glioma has completed Phase 1 and Phase 2. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• BiCNU (carmustine)
• Efaproxiral (efaproxiral)

Snippet

Sponsor: New Approaches to Brain Tumor Therapy Consortium | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED